CMG Pharmaceutical Co., Ltd.
CMG Pharmaceutical, a Cha Bio Group affiliate, develops ODF-based improved drugs using its STARFILM technology.
As of 2026-10-10, CMG Pharmaceutical Co., Ltd. has 1 Korean MFDS device approval, 353 Korean MFDS drug approvals, 4 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2001 and listed on KOSDAQ in 2001, CMG Pharmaceutical is a core affiliate of Cha Bio Group whose main business is the R&D, production, and sale of pharmaceuticals and health functional foods. Using its core STARFILM technology for oral disintegrating films (ODF), it develops improved new drugs with differentiated taste and stability, while expanding its portfolio into anticancer, anti-aging, ophthalmic, health functional food, and mom-and-baby product lines. It also operates an animal pharmaceutical business through an affiliate and is pursuing continued development of new and improved drugs, along with clinical entry and out-licensing of innovative new drugs.
Products & technology
- STARFILM Technology (Oral Disintegrating Film, ODF)Core formulation technology applied to improved new drug development
Regulatory approvals
data.go.kr353 Korean MFDS drug approvals · 1980–2026 / 1 Korean MFDS device approvals · 2014
- MFDS drugCaremela cream(Hydroquinone)2026-09-30Drug · OTC · Notification202602937
- MFDS drugCMbio Tab.(Biotin)2026-09-11Drug · OTC · Notification202602727
- MFDS drugEdoxin Tab. 60mg(Edoxaban tosylate hydrate)2026-08-31Drug · Prescription · Approval202602541
- MFDS drugEdoxin Tab. 30mg(Edoxaban tosylate hydrate)2026-08-31Drug · Prescription · Approval202602542
- MFDS drugTezan Tab. 50mg2026-08-25Drug · Prescription · Approval202602462
- MFDS drugTezan tab. 25mg2026-08-25Drug · Prescription · Approval202602463
- MFDS drugCM SAMSOEUM Solution2026-08-25Drug · OTC · Notification202602485
- MFDS drugZaviron night soft cap.2026-07-15Drug · OTC · Notification202602046
- MFDS drugDestop cap.2026-07-07Drug · OTC · Notification202601973
- MFDS drugRotizet OD Tab. 10/20mg2026-06-30Drug · Prescription · Approval202601888
- MFDS drugRotizet OD Tab. 10/5mg2026-06-30Drug · Prescription · Approval202601889
- MFDS drugRotizet OD Tab. 10/10mg2026-06-30Drug · Prescription · Approval202601890
Show 68 more
- MFDS drugVonoprazan tab. 10mg2026-06-30Drug · Prescription · Approval202601911
- MFDS drugVonoprazan tab. 20mg2026-06-30Drug · Prescription · Approval202601912
- MFDS drugCMG pancreas tablet 250002026-06-29Drug · OTC · Approval202601827
- MFDS drugLinetry tab.2026-06-22Drug · OTC · Notification202601754
- MFDS drugMigline Tab.2026-06-19Drug · Prescription · Approval202601739
- MFDS drugDoneplus Tablet (Donepezil Hydrochloride,Memantine Hydrochloride)2026-06-10Drug · Prescription · Approval202601637
- MFDS drugActiveneo soft capsule2026-05-14Drug · OTC · Notification202601421
- MFDS drugEzverine Tab.2026-05-06Drug · OTC · Notification202601332
- MFDS drugOlo-Luce Eye drops 0.7%2025-12-26Drug · Prescription · Approval202503391
- MFDS drugCalsbone tab.2025-11-21Drug · OTC · Notification202503041
- MFDS drugCMPeratam inj. 2.25g(Piperacillin sodium. Tazobactam sodium)2025-10-28Drug · Prescription · Approval202502762
- MFDS drugMaxbb plus tab.2025-10-20Drug · OTC · Notification202502703
- MFDS drugCMPeratam Inj. 4.5g(Piperacillin sodium. Tazobactam sodium)2025-10-14Drug · Prescription · Approval202502650
- MFDS drugPipen Tablet(Pitavastatin,fenofibrate)2025-08-29Drug · Prescription · Approval202502273
- MFDS drugCubit Soft caps.2025-06-18Drug · OTC · Notification202501497
- MFDS drugDabislim Tab.2025-06-16Drug · OTC · Notification202501467
- MFDS drugZescool plus Tab.2025-06-12Drug · OTC · Notification202501437
- MFDS drugTranexan cap.2025-03-26Drug · Prescription · Approval202500704
- MFDS drugDiastop capsule2025-01-08Drug · OTC · Notification202500070
- MFDS drugCaresmin tab.2025-01-07Drug · OTC · Notification202500051
- MFDS drugForsone tab.2025-01-06Drug · OTC · Notification202500033
- MFDS drugTORAPHEN XR TAB 25mg2024-12-12Drug · Prescription · Approval202402953
- MFDS drugLoxopop plasta2024-12-11Drug · OTC · Notification202402921
- MFDS drugTyxen Powder 160mg2024-12-10Drug · OTC · Notification202402904
- MFDS drugTyxen Powder 500mg2024-12-10Drug · OTC · Notification202402905
- MFDS drugCHEOLSWON Tab.2024-12-03Drug · OTC · Notification202402856
- MFDS drugDiqualux Eye Drops. (single use)2024-12-03Drug · Prescription · Approval202402860
- MFDS drugTORAPHENXR TAB 50mg2024-11-29Drug · Prescription · Approval202402827
- MFDS drugSiman solution2024-11-25Drug · OTC · Notification202402767
- MFDS drugWincold Cough Soft Cap.2024-10-11Drug · OTC · Notification202402410
- MFDS drugWin-cold Soft cap.2024-10-08Drug · OTC · Notification202402400
- MFDS drugOnecold all cough sol.2024-09-19Drug · OTC · Notification202402262
- MFDS drugOnecold Syrup2024-09-10Drug · OTC · Notification202402198
- MFDS drugOnecoldcough Syrup2024-09-10Drug · OTC · Notification202402199
- MFDS drugNosefor Nasal spray2024-09-02Drug · OTC · Notification202402127
- MFDS drugOnecoldnose Syrup2024-08-26Drug · OTC · Notification202402040
- MFDS drugGINKGOMIRAN TAB. 240mg2024-08-26Drug · OTC · Notification202402041
- MFDS drugTokTok Eye Eye drops2024-07-29Drug · OTC · Notification202401832
- MFDS drugAlletoc Tab. 120mg2024-07-23Drug · OTC · Notification202401781
- MFDS drugDexicen Soft Capsule2024-07-15Drug · OTC · Notification202401742
- MFDS drugNbreas capsule2024-06-28Drug · OTC · Notification202401588
- MFDS drugMaxbb tab.2024-06-21Drug · OTC · Notification202401505
- MFDS drugA A Force solution2024-06-03Drug · OTC · Notification202401381
- MFDS drugIbucen Soft Cap.2024-05-28Drug · OTC · Notification202401305
- MFDS drugIbucen eve Soft cap.2024-05-02Drug · OTC · Notification202401092
- MFDS drugFreesdam tablet2024-04-30Drug · OTC · Notification202401045
- MFDS drugTyribin Powder2024-04-29Drug · OTC · Notification202401033
- MFDS drugWin-cold Co Soft Cap.2024-04-18Drug · OTC · Notification202400884
- MFDS drugWhitetion tab.2024-04-18Drug · OTC · Notification202400885
- MFDS drugWin-cold Soft cap.Revoked2024-04-16Drug · OTC · Notification202400856
- MFDS drugWincold Cough Soft Cap.Revoked2024-04-16Drug · OTC · Notification202400857
- MFDS drugCMG View Plus soft capsule2024-03-26Drug · OTC · Notification202400647
- MFDS drugCHAMG soft capsule2024-03-26Drug · OTC · Notification202400653
- MFDS drugCMG Ambroxol Tablet2024-03-26Drug · OTC · Notification202400659
- MFDS drugCMG Mag Soft Cap.2024-03-21Drug · OTC · Notification202400582
- MFDS drugCMG Nicergoline Tab. 30mg2024-02-29Drug · Prescription · Approval202400438
- MFDS drugAlletoc Tab. 60mg2024-02-06Drug · OTC · Notification202400279
- MFDS drugCMG Kyungokgo2024-01-30Drug · OTC · Notification202400230
- MFDS drugCMG ssingssing syrup2024-01-22Drug · OTC · Notification202400148
- MFDS drugNarafil ODF 2.5mg2024-01-12Drug · Prescription · Approval202400098
- MFDS drugCMG Galgeuntang Solution2023-11-06Drug · OTC · Notification202303067
- MFDS drugOnecolenneck Soft Extract(Gupunghaedoktang)2023-11-02Drug · OTC · Notification202303051
- MFDS drugCMG Ssangwhatang Solution2023-11-02Drug · OTC · Notification202303053
- MFDS drugCMG Mag Solution2023-09-18Drug · OTC · Notification202302769
- MFDS drugIbupop plaster(Ibuprofen)2023-09-13Drug · OTC · Notification202302745
- MFDS drugCMG Lux plus eye drop 1.0%2023-08-23Drug · OTC · Notification202302508
- MFDS drugC-cox-plus tab.2023-08-10Drug · Prescription · Approval202302410
- MFDS drugTyxen tablet 500mg(Acetaminophen)2023-07-12Drug · OTC · Notification202302139
Showing the 80 most recent of 354 records.
Clinical trials
data.go.kr38 MFDS clinical trial authorisations · 2013–2026 (Bioequivalence 32 · Phase 1 4 · Phase 3 2)
- BioequivalenceCGN2601-T2026-09-29
1 trial site
- BioequivalenceCGC25012026-03-20
1 trial site
- BioequivalenceCGN25012026-03-17
1 trial site
- Bioequivalence도네듀오정10/20mg(도네페질염산염수화물, 메만틴염산염)2025-04-18
1 trial site
- Phase 1CMG1904042024-09-26
2 trial sites
- Bioequivalence레미피드서방정150밀리그램(레바미피드)2024-09-02
1 trial site
- Bioequivalence카르디날정12.5밀리그램2024-08-08
1 trial site
- Bioequivalence레미피드서방정150밀리그램(레바미피드)2024-07-18
1 trial site
- Bioequivalence에독신정60밀리그램(에독사반토실산염수화물)2023-11-01
1 trial site
- Bioequivalence테잔정50밀리그램(테고프라잔)2023-09-26
1 trial site
- Phase 3CMG1903032023-07-26
24 trial sites
- Bioequivalence레미피드서방정150밀리그램(레바미피드)2023-07-04
1 trial site
Show 26 more
- Bioequivalence레미피드서방정150밀리그램(레바미피드)2023-06-01
1 trial site
- Bioequivalence레드로진정(레보드로프로피진)2022-12-28
2 trial sites
- Phase 1CMG1904042022-02-28
2 trial sites
- Bioequivalence씨콕스캡슐200mg(세레콕시브)2021-12-06
1 trial site
- Bioequivalence타리원정10mg(베포타스틴베실산염)2021-11-11
2 trial sites
- Bioequivalence나라필구강용해필름2.5밀리그램(나라트립탄염산염)2021-07-02
2 trial sites
- Phase 1CMG1903032021-02-24
2 trial sites
- Phase 1CMG1903032020-08-14
2 trial sites
- Bioequivalence카르디날정25mg(카르베딜롤)2020-01-08
2 trial sites
- Phase 3씨엠지올리스타트정120mg(CMG-OLT-120)2019-09-04
6 trial sites
- Bioequivalence텔로듀오정80/20밀리그램2019-08-20
2 trial sites
- Bioequivalence도네시아정10mg(도네페질염산염)2018-10-29
2 trial sites
- Bioequivalence아모르탄정10/160mg2015-12-03
2 trial sites
- Bioequivalence씨엠지라베프라졸정20mg(라베프라졸나트륨)2015-12-03
2 trial sites
- Bioequivalence에소넬정40mg(에스오메프라졸마그네슘이수화물)2015-11-25
2 trial sites
- Bioequivalence씨엠지암로디핀정5mg(암로디핀베실산염)2015-11-25
1 trial site
- Bioequivalence로피렐정(클로피도그렐황산염)2015-11-19
2 trial sites
- Bioequivalence아로토정(아토르바스타틴칼슘)2015-11-04
2 trial sites
- Bioequivalence제대로필구강붕해필름5밀리그램(타다라필)2015-07-22
2 trial sites
- Bioequivalence씨콕스정2014-10-30
2 trial sites
- Bioequivalence엔테카비르 OTF 구강붕해필름(가칭)2014-10-15
2 trial sites
- Bioequivalence타다라필 OTF 구강붕해필름(가칭)2014-08-20
2 trial sites
- Bioequivalence아리피프라졸 OTF 10mg2014-07-30
2 trial sites
- Bioequivalence쎄레콕시브정2014-06-26
2 trial sites
- Bioequivalence아제탄정(염산아젤라스틴)2013-12-20
2 trial sites
- Bioequivalence씨엠지로수바스타틴정 10mg(로수바스타틴칼슘)2013-06-11
2 trial sites
Global clinical trials
ClinicalTrials.gov · sponsor-matchedPhase 3 · Recruiting · 2024-04 · NCT06772168
Phase 1 · Completed · 2015-10 · NCT02501109
Key disclosures
KRX KIND via OpenDARTPublications
PubMed · affiliation-matched- Single oral toxicity assessment and phytochemical analysis of the Ficus erecta Thunb. Leaves extract.
Toxicon : official journal of the International Society on Toxinology · 2025-01 · Kim YJ, Lee MY, Park HJ 외 6
- Anti-dyslipidemic effects of Pueraria lobata root and Glycine max (L.) Merrill extracts fermented with Lactiplantibacillus plantarum in ovariectomized mice.
Food science & nutrition · 2024-10 · Jang HM, Ha J, Choi I
- Preclinical efficacy of a novel dual PI3K/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma.
Cancer chemotherapy and pharmacology · 2019-10 · Kim MN, Lee SM, Kim JS 외 1
- A novel PI3K/mTOR dual inhibitor, CMG002, overcomes the chemoresistance in ovarian cancer.
Gynecologic oncology · 2019-04 · Choi HJ, Heo JH, Park JY 외 7
Patents
KIPRIS · applicant-matchedPublished · 2025-10 · Application 1020250157279
Published · 2025-01 · Application 1020250001796
Published · 2024-12 · Application 1020240187534
Published · 2024-11 · Application 1020240157501
PCT · Published · 2024-09 · Application PCT/KR2024/013192
Published · 2024-03 · Application 1020240035449
Registered · 2023-10 · Application 1020230138657
US · Published · 2023-06 · Application 18337732
Published · 2023-01 · Application 1020247031079
US · Published · 2023-01 · Application 18839273
Show 29 more patents
EP · Published · 2023-01 · Application 23755964.6
PCT · Published · 2023-01 · Application PCT/IB2023/050812
PCT · Published · 2023-01 · Application PCT/IB2023/050810
US · Registered · 2023-01 · Application 18161678
US · Published · 2023-01 · Application 18161609
PCT · Published · 2021-11 · Application PCT/KR2021/017886
Registered · 2020-12 · Application 1020200180144
Registered · 2020-11 · Application 1020200150555
US · Registered · 2019-03 · Application 16361908
PCT · Published · 2019-03 · Application PCT/IB2019/052367
PCT · Published · 2016-05 · Application PCT/KR2016/005660
CN · Published · 2015-12 · Application 201580075880.1
Rejected · 2015-12 · Application 1020247012821
Registered · 2015-12 · Application 1020177018519
US · Registered · 2015-12 · Application 14968208
EP · Published · 2015-12 · Application 24169331.6
EP · Registered · 2015-12 · Application 15869420.8
PCT · Published · 2015-12 · Application PCT/IB2015/002521
Rejected · 2015-05 · Application 1020150075053
US · Registered · 2015-02 · Application 14622447
Registered · 2013-10 · Application 1020130122476
US · Registered · 2013-08 · Application 14419231
EP · Registered · 2013-08 · Application 13828386.6
Expired · 2013-03 · Application 1020147029388
EP · Published · 2013-03 · Application 13763756.7
Registered · 2012-08 · Application 1020120086749
Registered · 2012-05 · Application 1020120046954
Expired · 2009-10 · Application 1020090099272
Expired · 2009-10 · Application 1020090099257
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIChatGPT-Userlive2
- OpenAIOAI-SearchBot36
- PerplexityPerplexityBot5
- AnthropicClaudeBot2
- GoogleGoogleOther1
Measured since Aug 27, 2026 · 4 AI engines · last read Oct 8, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for CMG Pharmaceutical Co., Ltd. and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies approved for the same productsPharma & CDMO
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.
KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.
Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.
KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.
Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.
KOSDAQ-listed IVD company producing time-resolved fluorescence immunodiagnostic products under the Exdia TRF brand.
Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.
Founded in 2003 and KOSPI-listed in 2022, BioNote develops and manufactures animal diagnostic reagents and bio-content materials.
GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.
Kwangdong Pharmaceutical, founded in 1963 and KOSPI-listed in 1989, manufactures prescription drugs and beverages.
KOSDAQ-listed bioprocess and biomedical company supplying the CELBIC single-use cell culture system and the DxBIC automated analysis system.
KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition